Clinical Trial Update: Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dose-adjustment of enoxaparin in pediatric kidney transplant recipients using a Bayesian pharmacological approach; study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplantation

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pediatric Kidney Transplant Recipients | Phase 4 | Status: COMPLETED